These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 36844819)
1. Carbapenem-resistant Huang W; Wei X; Xu G; Zhang X; Wang X Front Public Health; 2023; 11():1088262. PubMed ID: 36844819 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa. Tsao LH; Hsin CY; Liu HY; Chuang HC; Chen LY; Lee YJ J Microbiol Immunol Infect; 2018 Jun; 51(3):359-366. PubMed ID: 28988663 [TBL] [Abstract][Full Text] [Related]
3. Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections. Lin KY; Lauderdale TL; Wang JT; Chang SC J Microbiol Immunol Infect; 2016 Feb; 49(1):52-9. PubMed ID: 24662016 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital. Zhang D; Cui K; Wang T; Shan Y; Dong H; Feng W; Ma C; Dong Y J Infect Dev Ctries; 2018 Aug; 12(8):642-648. PubMed ID: 31958327 [TBL] [Abstract][Full Text] [Related]
5. Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study. Coppry M; Jeanne-Leroyer C; Noize P; Dumartin C; Boyer A; Bertrand X; Dubois V; Rogues AM J Antimicrob Chemother; 2019 Feb; 74(2):503-510. PubMed ID: 30376042 [TBL] [Abstract][Full Text] [Related]
6. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa. Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230 [TBL] [Abstract][Full Text] [Related]
7. Carbapenem Resistant Qin J; Zou C; Tao J; Wei T; Yan L; Zhang Y; Wang H Infect Drug Resist; 2022; 15():2301-2314. PubMed ID: 35517901 [TBL] [Abstract][Full Text] [Related]
8. [The impact of carbapenem-resistance Wei J; Zhu QL; Sun Z; Wang C Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):353-359. PubMed ID: 32370463 [No Abstract] [Full Text] [Related]
9. The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis. Chen Z; Xu Z; Wu H; Chen L; Gao S; Chen Y Am J Infect Control; 2019 Jun; 47(6):677-682. PubMed ID: 30554879 [TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Carbapenem-resistant Pseudomonas aeruginosa Infection in Children. Li L; Huang Y; Tang Q; Zheng Y Pediatr Infect Dis J; 2022 Aug; 41(8):642-647. PubMed ID: 35446814 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of a hospital outbreak related to carbapenem-resistant Pseudomonas aeruginosa]. Cekin Y; Karagöz A; Kızılateş F; Cekin AH; Oztoprak Çuvalcı N; Bülbüller N; Durmaz R Mikrobiyol Bul; 2013 Oct; 47(4):619-27. PubMed ID: 24237430 [TBL] [Abstract][Full Text] [Related]
12. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit. Kohlenberg A; Weitzel-Kage D; van der Linden P; Sohr D; Vögeler S; Kola A; Halle E; Rüden H; Weist K J Hosp Infect; 2010 Apr; 74(4):350-7. PubMed ID: 20170982 [TBL] [Abstract][Full Text] [Related]
13. Epidemiological and Genetic Characteristics of Clinical Carbapenem-Resistant Zhao Y; Chen D; Chen K; Xie M; Guo J; Chan EWC; Xie L; Wang J; Chen E; Chen S; Chen W; Jelsbak L Microbiol Spectr; 2023 Jun; 11(3):e0426122. PubMed ID: 37078855 [TBL] [Abstract][Full Text] [Related]
14. Risk factors and mortality of carbapenem-resistant Pseudomonas aeruginosa bloodstream infection in haematology department: A 10-year retrospective study. Yuan F; Li M; Wang X; Fu Y J Glob Antimicrob Resist; 2024 Jun; 37():150-156. PubMed ID: 38615882 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial Susceptibility Trends and Risk Factors for Antimicrobial Resistance in Kang JS; Moon C; Mun SJ; Lee JE; Lee SO; Lee S; Lee SH J Korean Med Sci; 2021 Nov; 36(43):e273. PubMed ID: 34751008 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome. Jeong SJ; Yoon SS; Bae IK; Jeong SH; Kim JM; Lee K Diagn Microbiol Infect Dis; 2014 Oct; 80(2):130-5. PubMed ID: 25112900 [TBL] [Abstract][Full Text] [Related]
17. Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Zhen S; Zhao Y; Chen Z; Zhang T; Wang J; Jiang E; Zhang F; Mi Y; Zhu X; Han M; Xiao Z; Wang J; Feng S Front Cell Infect Microbiol; 2023; 13():1156651. PubMed ID: 37415825 [TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa, Zhejiang Province, China. Hu YY; Cao JM; Yang Q; Chen S; Lv HY; Zhou HW; Wu Z; Zhang R Emerg Infect Dis; 2019 Oct; 25(10):1861-1867. PubMed ID: 31538558 [TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients. Pettigrew MM; Gent JF; Kong Y; Halpin AL; Pineles L; Harris AD; Johnson JK Clin Infect Dis; 2019 Aug; 69(4):604-613. PubMed ID: 30383203 [TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant Pseudomonas aeruginosa infections pose growing threat to health care-associated infection control in the hospitals of Southern China: a case-control surveillance study. Peng Y; Bi J; Shi J; Li Y; Ye X; Chen X; Yao Z Am J Infect Control; 2014 Dec; 42(12):1308-11. PubMed ID: 25444305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]